BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 2, 2001
View Archived Issues
Epigenomics and MethylGene to collaborate on study of DNA methylation pattern changes
Read More
Xerion and Byk Gulden collaborate on target validation
Read More
Microbiotix and Phytobiotech to develop novel antibiotics
Read More
Biovail and GSK sign Wellbutrin and Zovirax licensing agreements
Read More
New compound discovered as a result of continued focus on topoisomerase inhibitors at Xenova
Read More
Canadian team designs bifunctional nitrosourea with signal transduction-inhibitory effects
Read More
Low-molecular-weight PAI-1 inhibitors show potential therapeutic efficacy for cancer
Read More
Lilly presents detailed update of late- and early-stage product pipeline
Read More
Novel antiangiogenic agent targeting alpha5beta1 integrin presented at AACR-NCI-EORTC meeting
Read More
Texas Biotechnology updates clinical trial progress
Read More
CEP-5214, a new VEGF receptor tyrosine kinase inhibitor, effective in prostate tumor models
Read More
Phase I/II trial of CpG-7909/Herceptin commences in treatment of breast cancer
Read More
Inhibition of histone deacetylase safely suppresses tumor growth in ovarian cancer-bearing mice
Read More
TolerRx to advance lead product with completion of financing
Read More
OvaRex associated with improvement in clinical outcome and good safety in advanced ovarian cancer
Read More
Abbott's new H3 receptor antagonists described in recent patent
Read More
Diagnostic and therapeutic radiolabeled epothilone derivatives
Read More
Nucleosides useful as antiviral and anticancer agents disclosed by SRI
Read More
Significant antitumor activity and excellent safety demonstrated for ACRL-B4
Read More
AC-90179, a new 5-HT2A inverse agonist from Acadia
Read More
New chemokine IL-8 receptor antagonists under study at GSK
Read More